NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM

Publication Date

2024

Content Type

Article

PubMed ID:

38874333

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS